A Phase 1 Study to Evaluate the Safety and Pharmacokinetic Profile of CBLB502 in Patients With Advanced Cancers.
Phase of Trial: Phase I
Latest Information Update: 26 Jan 2016
At a glance
- Drugs Entolimod (Primary) ; Entolimod (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Status changed from active, no longer recruiting to completed, based on results reported at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).
- 01 Jun 2015 Results published in the Cleveland BioLabs media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History